Titus B. Ball - Jun 10, 2025 Form 4 Insider Report for BeOne Medicines Ltd. (ONC)

Role
Principal Accounting Officer
Signature
/s/ Qing Nian, as Attorney-in-Fact
Stock symbol
ONC
Transactions as of
Jun 10, 2025
Transactions value $
-$34,620
Form type
4
Date filed
6/12/2025, 05:51 PM
Previous filing
Sep 5, 2024
Next filing
Sep 4, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ball Titus B. Principal Accounting Officer C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, SWITZERLAND /s/ Qing Nian, as Attorney-in-Fact 2025-06-12 0001675628

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ONC Ordinary Shares Award $0 +29.6K +66.7% $0.00 74K Jun 10, 2025 Direct F1
transaction ONC American Depositary Shares Sale -$34.6K -134 -100% $258.36 0 Jun 11, 2025 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 10, 2025, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
F2 Each American Depositary Share represents 13 Ordinary Shares.
F3 The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2024, subject to continued service.